SD-169 ≥99% ATP-competitive p38alpha MAPK inhibitor

Potent, selective and ATP-competitive p38α MAPK inhibitor (IC₅₀ values are 3.2 and 122 nM for α and β, respectively). Orally active. Promotes axonal regeneration in vivo.

 : All products are FOR RESEARCH USE ONLY. PRODUCTS ARE NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES. Customer is granted a limited use non-exclusive licence for its own internal research. Any control manufacturer supplies with a Product is limited to use only to validate the relevant Product. By using the Product, Customers agree not to attempt to reverse engineer or otherwise perform any compositional, structural, functional or other analyses directed to learning the methodology, formulae, sequences, processes, make-up or production of any of the Products or portions thereof.